Biotin Conjugated Human IL-17A Recombinant Rabbit Monoclonal Antibody [PS01-24] (HA721631)
Catalog# HA721631
Rabbit Monoclonal to Human IL-17A
Tested for
-
ELISA(Det)
Reacts with
-
Human
Recombinant production enables lot-to-lot consistency and is animal-cruelty-free
Conjugated to Biotin
Advantages of Using rAbs：
Increased Reproducibility
Because recombinant antibody production involves sequencing the antibody light and heavy chains, recombinant antibody production allows researchers more control over the antigen.
Ease of Scalability and Continuous Supply
In vitro methods for producing antibodies are amenable to large-scale production, meaning antibody availability is unlikely to become a limiting factor. Recombinant antibodies can be produced in weeks as opposed to months.
Animal-Free Tech
Once the antibody-producing genes are isolated, high-throughput in vitro manufacture can be implemented. This eliminates the numerous ethical and animal welfare concerns commonly associated with traditional monoclonal antibody production.
Increased Reproducibility
Because recombinant antibody production involves sequencing the antibody light and heavy chains, recombinant antibody production allows researchers more control over the antigen.
Ease of Scalability and Continuous Supply
In vitro methods for producing antibodies are amenable to large-scale production, meaning antibody availability is unlikely to become a limiting factor. Recombinant antibodies can be produced in weeks as opposed to months.
Animal-Free Tech
Once the antibody-producing genes are isolated, high-throughput in vitro manufacture can be implemented. This eliminates the numerous ethical and animal welfare concerns commonly associated with traditional monoclonal antibody production.